Laurus Labs Acquires 52% Stake in SI&C Resins for ₹30 Cr

Laurus Labs Ltd has announced the acquisition of a 52% stake in SI & C Resins Private Limited (SI&C) for a pre-money valuation of ₹30 Crore. The company will invest ₹32.50 Crores through primary acquisition of equity shares. SI&C specializes in polymer and silica-based products for the chemical, pharmaceutical, and biotechnology sectors. This acquisition is part of Laurus Labs' peptide strategy, aiming to achieve fully integrated peptide manufacturing. SI&C, recently incorporated in July 2026, will become a subsidiary of Laurus Labs. The company may further invest up to ₹30 Crores in SI&C as needed. The acquisition is expected to be completed within the current financial year and is considered a cash consideration. It is not a related party transaction, and the promoter/promoter group has no interest in SI&C.